regn3767
mAbexperimental
Clinical trial activity
27 trials · 21 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
22
Phase 3
6
Phase 4
0
Earliest trial started Nov 1, 2016 (NCT03005782)
Timeline
Indications
Studied for
- Carcinoma, Non-Small-Cell Lung · Phase 2/Phase 3
- Carcinoma, Renal Cell · Phase 2
- Carcinoma, Squamous Cell · Phase 2
- Colonic Neoplasms · Phase 2
- Colorectal Neoplasms · Phase 2
- Head and Neck Neoplasms · Phase 2
- Lung Neoplasms · Phase 2
- Lymphoma, Large-Cell, Immunoblastic · Early Phase 1
- Melanoma · Phase 3
- Neoplasms · Phase 2
- Ovarian Neoplasms · Phase 2
- Squamous Cell Carcinoma of Head and Neck · Phase 2
- Urinary Bladder Neoplasms · Phase 2
Mechanism of action
- Lymphocyte activation gene 3 proteinINHIBITOR
Lymphocyte activation gene 3 protein inhibitor
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL4298085 ↗
Also known as
- regn3767
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07281768 | Phase 2 | Mar 31, 2026 | Johns Hopkins University, Regeneron |
| NCT07224022 | Phase 2 | Jan 31, 2026 | Duke University, Regeneron |
| NCT07179315 | Phase 2 | Jan 1, 2026 | University of Chicago |
| NCT07223541 | Phase 2 | Dec 31, 2025 | Regeneron, University of Oklahoma |
| NCT07188896 | Phase 2 | Nov 30, 2025 | Hoosier Cancer Research Network, Regeneron, Vanderbilt University |
| NCT06865339 | Phase 2 | Aug 7, 2025 | Henry Ford Health System, New York University, Regeneron, University of Michigan, Yeshiva University |
| NCT07058012 | Phase 2 | Aug 1, 2025 | NSABP Foundation, Regeneron |
| NCT06887088 | Phase 2 | May 29, 2025 | Grupo Español Multidisciplinar de Melanoma, Hospital General Universitario Gregorio Marañon, MFAR Clinical Research, Pierre Fabre, Regeneron |
| NCT06787612 | Phase 2 | May 1, 2025 | Regeneron |
| NCT06918132 | Phase 2 | Apr 29, 2025 | Mayo Clinic |
| NCT06848088 | Phase 2 | Apr 14, 2025 | Regeneron |
| NCT06769698 | Phase 2 | Mar 26, 2025 | Regeneron |
| NCT06699602 | Phase 2 | Dec 31, 2024 | Memorial Sloan-Kettering Cancer Center |
| NCT06571708 | Phase 2 | Nov 30, 2024 | Columbia University, Regeneron |
| NCT06384820 | Phase 2 | Nov 14, 2024 | Regeneron |
| NCT06190951 | Phase 2/Phase 3 (Phase 3) | Sep 18, 2024 | Regeneron |
| NCT06594991 | Phase 2 | Sep 10, 2024 | Memorial Sloan-Kettering Cancer Center, Regeneron |
| NCT06246916 | Phase 3 | Sep 9, 2024 | Regeneron |
| NCT06205836 | Phase 2 | Jun 13, 2024 | Johns Hopkins University, Regeneron |
| NCT06161441 | Phase 2 | Mar 5, 2024 | Regeneron |
Showing 20 of 27 trials
Page 1 / 2
Organizations
Research & Development (21)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Regeneron | For profit | 23 | 12 | 3 | 2016 |
| Memorial Sloan-Kettering Cancer Center | Academic/Hospital | 3 | 3 | 2 | 2020 |
| Johns Hopkins University | Academic/Hospital | 2 | 2 | 1 | 2024 |
| Columbia University | Academic/Hospital | 1 | 1 | 1 | 2024 |
| Duke University | Academic/Hospital | 1 | 1 | 1 | 2026 |
| Grupo Español Multidisciplinar de Melanoma | Academic/Hospital | 1 | 1 | 1 | 2025 |
| Henry Ford Health System | Academic/Hospital | 1 | 0 | 1 | 2025 |
| Hoosier Cancer Research Network | Academic/Hospital | 1 | 1 | 1 | 2025 |
| Hospital General Universitario Gregorio Marañon | Academic/Hospital | 1 | 0 | 1 | 2025 |
| Mayo Clinic | Academic/Hospital | 1 | 1 | 1 | 2025 |
| MFAR Clinical Research | For profit | 1 | 0 | 1 | 2025 |
| New York University | Academic/Hospital | 1 | 0 | 1 | 2025 |
| NSABP Foundation | Academic/Hospital | 1 | 1 | 1 | 2025 |
| Pierre Fabre | For profit | 1 | 0 | 1 | 2025 |
| Sanofi | For profit | 1 | 0 | 1 | 2016 |
| University of Chicago | Academic/Hospital | 1 | 1 | 1 | 2026 |
| University of Groningen | Academic/Hospital | 1 | 1 | 1 | 2021 |
| University of Michigan | Academic/Hospital | 1 | 0 | 1 | 2025 |
| University of Oklahoma | Academic/Hospital | 1 | 1 | 1 | 2025 |
| Vanderbilt University | Academic/Hospital | 1 | 0 | 1 | 2025 |
21 organizations
Page 1 / 2